We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.32%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.11%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOG icon
576
EOG Resources
EOG
$76.4B
$164K 0.02%
1,692
-1,321
-44% -$116K
NUS icon
577
Nu Skin
NUS
$259M
$164K 0.02%
+2,535
New +$143K
NVR icon
578
NVR
NVR
$16.8B
$164K 0.02%
100
+5
+5% +$8.52K
BWA icon
579
BorgWarner
BWA
$12.9B
$163K 0.02%
5,274
-9,618
-65% -$283K
DRI icon
580
Darden Restaurants
DRI
$23.4B
$163K 0.02%
2,660
-1,093
-29% -$67.8K
IDA icon
581
Idacorp
IDA
$8.36B
$163K 0.02%
2,080
-2,435
-54% -$192K
PBYI icon
582
Puma Biotechnology
PBYI
$397M
$163K 0.02%
2,427
+1,740
+253% +$88K
LPNT
583
DELISTED
LifePoint Health, Inc.
LPNT
$163K 0.02%
2,756
+2,507
+1,007% +$150K
CLSD
584
DELISTED
Clearside Biomedical
CLSD
$162K 0.02%
621
+588
+1,782% +$72K
RYN icon
585
Rayonier
RYN
$6.6B
$162K 0.02%
6,717
-675
-9% -$16.5K
VPL icon
586
Vanguard FTSE Pacific ETF
VPL
$8.36B
$162K 0.02%
+2,675
New +$158K
LSI
587
DELISTED
Life Storage, Inc.
LSI
$162K 0.02%
2,727
-1,773
-39% -$113K
LLY icon
588
Eli Lilly
LLY
$995B
$161K 0.02%
2,002
-12,396
-86% -$992K
PFE icon
589
Pfizer
PFE
$145B
$161K 0.02%
5,018
-99,211
-95% -$3.32M
FDS icon
590
Factset
FDS
$9.76B
$160K 0.02%
988
-829
-46% -$143K
FXZ icon
591
First Trust Materials AlphaDEX Fund
FXZ
$383M
$160K 0.02%
+4,688
New +$160K
WLY icon
592
John Wiley & Sons Class A
WLY
$2.78B
$160K 0.02%
3,096
+2,946
+1,964% +$161K
SYY icon
593
Sysco
SYY
$39.6B
$159K 0.02%
3,249
+2,329
+253% +$120K
TPR icon
594
Tapestry
TPR
$31.5B
$159K 0.02%
4,374
+1,208
+38% +$47.9K
CXT icon
595
Crane NXT
CXT
$3.15B
$158K 0.02%
7,192
+5,039
+234% +$109K
SWC
596
DELISTED
Stillwater Mining Co
SWC
$158K 0.02%
11,875
-1,663
-12% -$22.3K
FTNT icon
597
Fortinet
FTNT
$123B
$157K 0.02%
21,215
-11,105
-34% -$77.6K
NXPI icon
598
NXP Semiconductors
NXPI
$59.9B
$157K 0.02%
1,538
-6,695
-81% -$567K
PEG icon
599
Public Service Enterprise Group
PEG
$38B
$157K 0.02%
+3,764
New +$166K
REG icon
600
Regency Centers
REG
$14.5B
$157K 0.02%
2,029
-4,953
-71% -$400K

Similar funds

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.